| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/25/2011 | CN102068663A Chinese medicinal formula for treating hyperlipoproteinemia |
| 05/25/2011 | CN102068625A Traditional Chinese medicinal composition for reducing blood sugar and blood pressure and preparation method thereof |
| 05/25/2011 | CN102068618A Traditional Chinese medicine for treatment of diabetic constipation |
| 05/25/2011 | CN102068609A Traditional Chinese medicine for treating diabetes mellitus |
| 05/25/2011 | CN102068589A Blood fat reducing and weight losing medicinal composition and preparation method thereof |
| 05/25/2011 | CN102068586A Preparation method and application of composite Chinese magnoliavine fruit preparation |
| 05/25/2011 | CN102068557A Application of Pu'er tea extract in preparation of medicines for reducing blood fat |
| 05/25/2011 | CN102068521A Traditional Chinese medicine composition for treating hyperlipidemia and preparation method and application thereof |
| 05/25/2011 | CN102068515A Traditional Chinese medicine for treatment of diabetic diarrhea |
| 05/25/2011 | CN102068513A Application of coptis astragalus scutellaria composition in preparation of drug for preventing and treating diabetic complication |
| 05/25/2011 | CN102068500A Traditional Chinese medicine for treatment of diabetic coronary heart disease |
| 05/25/2011 | CN102068480A Edible and medicinal compound preparation with effects of heatstroke alleviation and detoxification |
| 05/25/2011 | CN102068476A Novel use of panax notoginseng (Burk.)F.H.Chen |
| 05/25/2011 | CN102068475A Application and blood-sugar lowering effective part of trapa acornis nakano shell as well as extraction method of blood-sugar lowering effective part |
| 05/25/2011 | CN102068453A Stable complex vitamin composite and preparation method thereof |
| 05/25/2011 | CN102068441A Compound preparation containing telmisartan and glimepiride |
| 05/25/2011 | CN102068434A Application of 4-(cyclohexyl)-aminoquinazoline compounds |
| 05/25/2011 | CN102068427A Use of compound |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN101690777B Formula of polygonatum chewable tablets and preparation method thereof |
| 05/25/2011 | CN101653499B New application of peony blood stasis removing preparation in preparing medicaments for preventing or treating diabetic complication |
| 05/25/2011 | CN101637452B Atorvastatin calcium dried suspension and preparation method thereof |
| 05/25/2011 | CN101637220B Anti-virus feed additive for reducing cholesterol, production process thereof and application |
| 05/25/2011 | CN101579325B Metformin hydrochloride controlled-release tablet and preparation method thereof |
| 05/25/2011 | CN101559045B Arachidonic acid nutrition microcapsule with high temperature resistance and preparation method thereof |
| 05/25/2011 | CN101554374B Flavonoid compound with inhibit function for dipeptidyl peptidase IV |
| 05/25/2011 | CN101518575B Traditional Chinese medicine for treating diabetic insomnia |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 05/25/2011 | CN101342184B Use of oligosaccharides in preparing nutritional or pharmaceutical composition |
| 05/25/2011 | CN101306140B Traditional Chinese drug prescription special for weight reduction using Tibet cup |
| 05/25/2011 | CN101293081B Medicament for treating hyperlipemia and preparation method thereof |
| 05/25/2011 | CN101259102B Micrometre level docosahexaenoic acid emulsion and preparation thereof |
| 05/25/2011 | CN101239112B Chinese medicinal composition for regulating blood fat and preparation thereof |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101194998B Chinese medicine for treating diabetes |
| 05/25/2011 | CN101167862B Traditional Chinese medicine compound preparation for treating diabetes and nephrosis and preparing method thereof |
| 05/25/2011 | CN101077104B Gynostemma pentaphyllum tea |
| 05/25/2011 | CN101056628B Ester derivatives and medicinal use thereof |
| 05/25/2011 | CN101027286B Indozolone derivatives as 11b-HSD1 inhibitors |
| 05/25/2011 | CA2791796A1 Herbal supplement prepared from geranium |
| 05/24/2011 | US7947851 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947735 Compounds for the treatment of metabolic disorders |
| 05/24/2011 | US7947726 Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof |
| 05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
| 05/24/2011 | US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist |
| 05/24/2011 | US7947692 Substituted thiazolo[5,4-d]pyrimidine urea derivatives |
| 05/24/2011 | US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947303 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/24/2011 | CA2645967C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/24/2011 | CA2582767C Solid formulation with improved solubility and stability and method for producing said formulation |
| 05/24/2011 | CA2533196C Use of pinolenic acid and derivatives thereof for weight management |
| 05/24/2011 | CA2499690C Diaryl ethers as opioid receptor antagonist |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/19/2011 | WO2011059085A1 Prophylactic or therapeutic agent for dyslipidemia-related arteriosclerosis |
| 05/19/2011 | WO2011059053A1 Therapeutic or prophylactic agent for diabetes |
| 05/19/2011 | WO2011059042A1 Aromatic ring compound |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058975A1 Agent for ameliorating postprandial hyperglycemia, and pyrrolidine iminosugar or salt thereof |
| 05/19/2011 | WO2011058943A1 Pharmaceutical composition formed from combining compound having mch r1 antagonist activity and compound having npy y5 antagonist activity |
| 05/19/2011 | WO2011058773A1 Oil-based composition |
| 05/19/2011 | WO2011058474A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 05/19/2011 | WO2011058331A1 Pemirolast for the treatment of systemic low grade inflammation |
| 05/19/2011 | WO2011058193A1 [1,5]-diazocin derivatives |
| 05/19/2011 | WO2011058122A1 Piperidine analogs as glycogen synthase activators |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058083A1 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine |
| 05/19/2011 | WO2011058082A1 Pharmaceutical composition comprising a glp-1 agonist and methionine |
| 05/19/2011 | WO2011057956A1 Benzisoxazole analogs as glycogen synthase activators |
| 05/19/2011 | WO2011057471A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | WO2011057331A1 A method for treating obesity |
| 05/19/2011 | WO2011057326A1 Method of treatment of type 2 diabetes |
| 05/19/2011 | WO2011019752A3 A1 adenosine receptor agonist polymorphs |
| 05/19/2011 | WO2011018582A3 Floating microgranules |
| 05/19/2011 | WO2010144140A3 Egfr and par2 regulation of intestinal permeability |
| 05/19/2011 | WO2010074588A3 Pharmaceutical compounds |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118350 Composition for preventing cardiovascular event in high-risk patient |
| 05/19/2011 | US20110118345 Composition and method for treating diabetes and metabolic disorders |
| 05/19/2011 | US20110118344 Novel compound having inhibitory effect on lipase |
| 05/19/2011 | US20110118325 Rel inhibitors and methods of use thereof |
| 05/19/2011 | US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
| 05/19/2011 | US20110118321 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 05/19/2011 | US20110118314 Piperidine analogs as glycogen synthase activators |
| 05/19/2011 | US20110118305 Compounds |
| 05/19/2011 | US20110118302 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 05/19/2011 | US20110118300 Glucose metabolism modulating compounds |